These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


2306 related items for PubMed ID: 9815777

  • 1. Overexpression of epithelial macrophage colony-stimulating factor (CSF-1) and CSF-1 receptor: a poor prognostic factor in epithelial ovarian cancer, contrasted with a protective effect of stromal CSF-1.
    Chambers SK, Kacinski BM, Ivins CM, Carcangiu ML.
    Clin Cancer Res; 1997 Jun; 3(6):999-1007. PubMed ID: 9815777
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. p53 overexpression is not an independent prognostic factor for patients with primary ovarian epithelial cancer.
    Eltabbakh GH, Belinson JL, Kennedy AW, Biscotti CV, Casey G, Tubbs RR, Blumenson LE.
    Cancer; 1997 Sep 01; 80(5):892-8. PubMed ID: 9307189
    [Abstract] [Full Text] [Related]

  • 5. The role of colony-stimulating factor 1 and its receptor in the etiopathogenesis of endometrial adenocarcinoma.
    Smith HO, Anderson PS, Kuo DY, Goldberg GL, DeVictoria CL, Boocock CA, Jones JG, Runowicz CD, Stanley ER, Pollard JW.
    Clin Cancer Res; 1995 Mar 01; 1(3):313-25. PubMed ID: 9815987
    [Abstract] [Full Text] [Related]

  • 6. PEA3 is the second Ets family transcription factor involved in tumor progression in ovarian carcinoma.
    Davidson B, Goldberg I, Gotlieb WH, Kopolovic J, Ben-Baruch G, Reich R.
    Clin Cancer Res; 2003 Apr 01; 9(4):1412-9. PubMed ID: 12684413
    [Abstract] [Full Text] [Related]

  • 7. Ets-1 messenger RNA expression is a novel marker of poor survival in ovarian carcinoma.
    Davidson B, Reich R, Goldberg I, Gotlieb WH, Kopolovic J, Berner A, Ben-Baruch G, Bryne M, Nesland JM.
    Clin Cancer Res; 2001 Mar 01; 7(3):551-7. PubMed ID: 11297247
    [Abstract] [Full Text] [Related]

  • 8. Evidence for a dose-response effect between p53 (but not p21WAF1/Cip1) protein concentrations, survival, and responsiveness in patients with epithelial ovarian cancer treated with platinum-based chemotherapy.
    Levesque MA, Katsaros D, Massobrio M, Genta F, Yu H, Richiardi G, Fracchioli S, Durando A, Arisio R, Diamandis EP.
    Clin Cancer Res; 2000 Aug 01; 6(8):3260-70. PubMed ID: 10955812
    [Abstract] [Full Text] [Related]

  • 9. Prognostic significance of stromal metalloproteinase-2 in ovarian adenocarcinoma and its relation to carcinoma progression.
    Torng PL, Mao TL, Chan WY, Huang SC, Lin CT.
    Gynecol Oncol; 2004 Feb 01; 92(2):559-67. PubMed ID: 14766248
    [Abstract] [Full Text] [Related]

  • 10. c-erbB-2, p53, and nm23 proteins as prognostic factors in patients with epithelial ovarian carcinoma.
    Tomić S, Ilić Forko J, Babić D, Sundov D, Kuret S, Andelinović S.
    Croat Med J; 2003 Aug 01; 44(4):429-34. PubMed ID: 12950146
    [Abstract] [Full Text] [Related]

  • 11. Macrophage colony-stimulating factor mediates invasion of ovarian cancer cells through urokinase.
    Chambers SK, Wang Y, Gertz RE, Kacinski BM.
    Cancer Res; 1995 Apr 01; 55(7):1578-85. PubMed ID: 7882368
    [Abstract] [Full Text] [Related]

  • 12. Expression of chemokine CXCL12 and its receptor CXCR4 in human epithelial ovarian cancer: an independent prognostic factor for tumor progression.
    Jiang YP, Wu XH, Shi B, Wu WX, Yin GR.
    Gynecol Oncol; 2006 Oct 01; 103(1):226-33. PubMed ID: 16631235
    [Abstract] [Full Text] [Related]

  • 13. Alphav integrin expression is a novel marker of poor prognosis in advanced-stage ovarian carcinoma.
    Goldberg I, Davidson B, Reich R, Gotlieb WH, Ben-Baruch G, Bryne M, Berner A, Nesland JM, Kopolovic J.
    Clin Cancer Res; 2001 Dec 01; 7(12):4073-9. PubMed ID: 11751504
    [Abstract] [Full Text] [Related]

  • 14. Patterns of stromal invasion in ovarian serous tumors of low malignant potential (borderline tumors): a reevaluation of the concept of stromal microinvasion.
    McKenney JK, Balzer BL, Longacre TA.
    Am J Surg Pathol; 2006 Oct 01; 30(10):1209-21. PubMed ID: 17001150
    [Abstract] [Full Text] [Related]

  • 15. Expression of trypsinogen-1, trypsinogen-2, and tumor-associated trypsin inhibitor in ovarian cancer: prognostic study on tissue and serum.
    Paju A, Vartiainen J, Haglund C, Itkonen O, von Boguslawski K, Leminen A, Wahlström T, Stenman UH.
    Clin Cancer Res; 2004 Jul 15; 10(14):4761-8. PubMed ID: 15269150
    [Abstract] [Full Text] [Related]

  • 16. CD44 expression indicates favorable prognosis in epithelial ovarian cancer.
    Sillanpää S, Anttila MA, Voutilainen K, Tammi RH, Tammi MI, Saarikoski SV, Kosma VM.
    Clin Cancer Res; 2003 Nov 01; 9(14):5318-24. PubMed ID: 14614016
    [Abstract] [Full Text] [Related]

  • 17. TGF-beta receptor 2 downregulation in tumour-associated stroma worsens prognosis and high-grade tumours show more tumour-associated macrophages and lower TGF-beta1 expression in colon carcinoma: a retrospective study.
    Bacman D, Merkel S, Croner R, Papadopoulos T, Brueckl W, Dimmler A.
    BMC Cancer; 2007 Aug 10; 7():156. PubMed ID: 17692120
    [Abstract] [Full Text] [Related]

  • 18. Association of immunoreactive hepatocyte growth factor with poor survival in resectable non-small cell lung cancer.
    Siegfried JM, Weissfeld LA, Singh-Kaw P, Weyant RJ, Testa JR, Landreneau RJ.
    Cancer Res; 1997 Feb 01; 57(3):433-9. PubMed ID: 9012470
    [Abstract] [Full Text] [Related]

  • 19. Epithelial ovarian tumors in the reproductive age group: age is not an independent prognostic factor.
    Massi D, Susini T, Savino L, Boddi V, Amunni G, Colafranceschi M.
    Cancer; 1996 Mar 15; 77(6):1131-6. PubMed ID: 8635134
    [Abstract] [Full Text] [Related]

  • 20. Colony-stimulating factor-1 and its receptor do not have a role in the pathogenesis of uterine sarcomas.
    Anderson PS, Smith HO, Goldberg GL, Fields AL, Runowicz CD, Pollard JW.
    Gynecol Oncol; 1999 Aug 15; 74(2):202-7. PubMed ID: 10419732
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 116.